Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria

International Journal of Dermatology

Volumn 42, Issue SUPPL. 1, 2003, Pages 11-17

  Kokjohn, Katrina ^a   Bradley, Mary ^b   Griffiths, Brian ^a   Ghannoum, Mahmoud ^b  

^a Medics Pharmaceutical Corporation   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BUTENAFINE; CICLOPIROXOLAMINE; ECONAZOLE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CANDIDA ALBICANS; COMPARATIVE STUDY; CONTROLLED STUDY; CORYNEBACTERIUM; DERMATOMYCOSIS; DERMATOPHYTE; DILUTION; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; LABORATORY TEST; MALASSEZIA FURFUR; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS GROUP A; YEAST;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; BACTERIA; BENZYLAMINES; DRUG RESISTANCE, FUNGAL; ECONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; PYRIDONES; SENSITIVITY AND SPECIFICITY; YEASTS;

EID: 0141816869     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.42.s1.4.x     Document Type: Article

References (17)

1. Leyden JJ. Microbial ecology in interdigital "athlete foot" infection. Seminars Dermatol 1982; 1: 149-152.
2. Kates SG, Nordstrom KM, McGinley KJ, Leyden JJ. Microbial ecology of interdigital infections of toe web spaces. J Am Acad Dermatol 1990; 22: 578-582.
3. Ghannoum MA, Rice LB. Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Micro Rev 1999; 12: 501-517.
4. Hossain MA, Ghannoum MA. New developments in chemotherapy for non-invasive fungal infections. Expert Opin Invest Drugs 2001; 10: 1501-1511.
5. Gupta AK, Einarson TR, Summerbell RC, Shear NH. An overview of topical antifungal therapy in dermatomycoses. Drugs 1998; 55 (5): 645-674.
6. Brennan B, Leyden JJ. Overview of topical therapy for common superficial fungal infections and the role of new topical agents. J Am Acad Dermatol 1997; 36: S3-S8.
7. Markus A. Hydroxy-pryidones: Outstanding biological properties. In: Hydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis. Berlin: Springer-Verlag, 1999; 1-10.
8. Jessup CJ, Warner J, Isham N, Hasan I, et al. Antifungal susceptibility testing of dermatophyes: Establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol 2000; 38: 341-344.
9. NCCLS M27-A. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard. June 1997; 17: 1-29.
10. NCCLS M7-A5. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. 5th edn. January 2000; 20: 1-8.
11. Jue SG, Dawson GW, Brogden RN. Ciclopirox olamine 1% cream: A preliminary review of its antimicrobial activity and therapeutic use. Drugs 1985; 29: 330-341.
12. Niewerth M, Splanemann V, Korting HC, Ring J, et al. Antimicrobial susceptibility testing of dermatophytes - Comparison of the agar macrodilution and broth microdilution tests. Chemother 1998; 44: 31-35.
13. Brennan B, Leyden JJ. Overview of topical therapy for common superficial infections and the role of new topical agents. J Am Acad Dermatol 1997; 36: S3-S8.
14. Limbert M, Ulbrict H. In-vitro activity of ciclopiroxolamine and other antimycotics against Proteus mirabilis and Psuedomonas Aeruginosa. Hautnah Mykologie 1992; 1: 16-19.
15. Pierard GE, Pierard-Franchimont C, Estrada JA. Comparative study of the activity and lingering effect of topical antifungals. Skin Pharmacol 1993; 6: 208-214.
16. Leyden JJ, Kligman AM. Interdigital athlete's foot. Arch Dermatol 1978; 114: 1466-1472.
17. Talwar P, Kumar B, Ayyagiri A, Kaur S. Prevalence of bacteria and fungi in athlete's foot of varying severity and response to topical antibacterial and antifungal therapies. J Med Vet Mycol 1985; 23: 303-312.